ERBB2 and breast cancer: In view of the association of ErbB-2 over expression with poor prognosis in breast cancers the elucidation of these phenomena is of particular biological interest also in the context of the pharmacological relevance of ErbB-2 regulation, which, possibly, could be modulated via tuning of expression of the single htid splice forms.